| Novartis Pharma Schweiz AG - Votubia 2 mg, dispergierbare Tabletten | | 62812 | | 01 | | Votubia 2 mg | | dispergierbare Tabletten | | L01XE10 | | Everolimus | | 17.01.2014 | | |
| | Composition | | everolimusum 2 mg, lactosum monohydricum 1.96 mg, hypromellosum, mannitolum, cellulosum microcristallinum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, E 321 pro compresso. | | Packungsbestandteile | | Dispersible Tablets | | | | | Active Agent | Dose |
|---|
| Everolimus | 2 mg |
| | BAG: Active Agent | Dose |
|---|
| Everolimus | 2 mg |
| | | | Inactive agents | Dose |
|---|
| Cellulosum Microcristallinum | | | Crospovidonum | | | E 321 | | | Hypromellosum | | | Lactose Monohydrate | 1.96 mg | | Magnesii Stearas | | | Mannitol | | | Pro Compresso | | | Silica Colloidalis Anhydrica | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 Tablet(s) | 911.01 | 1007.20 | A | SL | Yes |
|
|
